BIOMARKER:

EGFR C797S + EGFR T790M + EGFR L858R

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	JIN-A02 Sensitive: D – Preclinical ESMO 2022 - 3 weeks (New D) JIN-A02 Sensitive : D ESMO 2022 - 3wk	JIN-A02 Sensitive: D – Preclinical ESMO 2022 - 3 weeks JIN-A02 Sensitive : D ESMO 2022 - 3 weeks - (New D)
EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D	CH7233163 Sensitive: D – Preclinical CH7233163 Sensitive : D
EGFR C797S + EGFR T790M + EGFR L858R	Lung Adenocarcinoma	EGFR C797S + EGFR T790M + EGFR L858R	Lung Adenocarcinoma	brigatinib + vorinostat Sensitive: D – Preclinical brigatinib + vorinostat Sensitive : D	brigatinib + vorinostat Sensitive: D – Preclinical brigatinib + vorinostat Sensitive : D
EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	OBX02-011 Sensitive: D – Preclinical OBX02-011 Sensitive : D	OBX02-011 Sensitive: D – Preclinical OBX02-011 Sensitive : D
EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	panitumumab + WX-0593 Sensitive: D – Preclinical panitumumab + WX-0593 Sensitive : D	panitumumab + WX-0593 Sensitive: D – Preclinical panitumumab + WX-0593 Sensitive : D
EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	HBI-2376 Sensitive: D – Preclinical HBI-2376 Sensitive : D	HBI-2376 Sensitive: D – Preclinical HBI-2376 Sensitive : D
EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	H002 Sensitive: D – Preclinical H002 Sensitive : D	H002 Sensitive: D – Preclinical H002 Sensitive : D
EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	14aj Sensitive: D – Preclinical 14aj Sensitive : D	14aj Sensitive: D – Preclinical 14aj Sensitive : D
EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	EGFR C797S + EGFR T790M + EGFR L858R	Non Small Cell Lung Cancer	WX-0593 + QL1203 Sensitive: D – Preclinical WX-0593 + QL1203 Sensitive : D	WX-0593 + QL1203 Sensitive: D – Preclinical WX-0593 + QL1203 Sensitive : D